An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations

Clinical trial NCT07037238 · RECRUITING

Trial details

NCT number: NCT07037238
Sponsor: Xuanwu Hospital, Beijing
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Vascular Malformations

Start date: 2025-07-01
Primary completion: 2026-07-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.